|
TOP NEWS
Yale, Biohaven Win $4M In Biotech Trade Secret Trial
By Ivan Moreno
A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.
2 documents attached |
Read full article »
| Save to favorites »
Del. Judge Tosses Challenge To Envestnet's $4.5B Bain Sale
By Jarek Rutz
The Delaware Chancery Court has dismissed a stockholder challenge to Envestnet Inc.'s $4.5 billion take-private sale to Bain Capital affiliates, ruling that investors approved the deal through a fully informed vote and that the complaint failed to support claims that the company's independent directors or financial adviser Morgan Stanley acted improperly.
Opinion attached |
Read full article »
| Save to favorites »
POLICY & REGULATION
SEC Fines Simplify $400K Over ETF Transaction Violations
By Katryna Perera
A Delaware-based registered investment adviser has agreed to pay a $400,000 fine to the U.S. Securities and Exchange Commission to resolve claims that, among other things, it caused an affiliated trust to engage in prohibited transactions and separately caused one of its exchange-traded funds to exceed leverage thresholds for derivatives trading.
Order attached |
Read full article »
| Save to favorites »
BANKRUPTCY COURT
DISTRICT COURT
EXPERT ANALYSIS
LEGAL INDUSTRY
|